2-Deoxy-2-fluoro-D-glucose structure
|
Common Name | 2-Deoxy-2-fluoro-D-glucose | ||
|---|---|---|---|---|
| CAS Number | 29702-43-0 | Molecular Weight | 182.147 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 478.4±45.0 °C at 760 mmHg | |
| Molecular Formula | C6H11FO5 | Melting Point | 170ºC | |
| MSDS | Chinese USA | Flash Point | 243.1±28.7 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 2-Deoxy-2-fluoro-D-glucose2-Deoxy-2-fluoro-D-glucose is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | 2-Deoxy-2-fluoro-D-glucose |
|---|---|
| Synonym | More Synonyms |
| Description | 2-Deoxy-2-fluoro-D-glucose is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 478.4±45.0 °C at 760 mmHg |
| Melting Point | 170ºC |
| Molecular Formula | C6H11FO5 |
| Molecular Weight | 182.147 |
| Flash Point | 243.1±28.7 °C |
| Exact Mass | 182.059052 |
| PSA | 97.99000 |
| LogP | -2.37 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.505 |
| Storage condition | 2-8°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2932999099 |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Lancet 383(9918) , 705-13, (2014) The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We ... |
|
|
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
J. Nucl. Med. 55(5) , 749-52, (2014) We prospectively compared (11)C-acetate with (18)F-FDG in a PET/CT evaluation of multiple myeloma (MM), specifically on diagnostic accuracy, identification of high-risk patients, and monitoring of tre... |
|
|
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
J. Nucl. Med. 56(1) , 127-32, (2015) Idiopathic pulmonary fibrosis is characterized by a progressive and irreversible respiratory failure. Validated noninvasive methods able to assess disease activity are essential for prognostic purpose... |
| 2-fluoro-2-deoxyglucose |
| 2-DEOXY-2-FLUOROGLUCOSE |
| 2-Deoxy-2-fluoro-D-glucopyranose |
| 2-[(18)F]fluorodeoxyglucose |
| 2-Deoxy-2-fluoro-D-glucose |
| 2-Fluoro-2-deoxy-D-glucopyranose |
| 2-deoxy-2-fluoro-aldehydo-D-glucose |
| D-Glucose,2-deoxy-2-fluoro |
| D-Glucose, 2-deoxy-2-fluoro- |
| 2-Fluoro-2-Deoxy-D-Glucose |
| MFCD00077527 |